APO Research
Talk to an analyst

APO RESEARCH · REPORT

Carbetocin (Duratocin)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Carbetocin (Duratocin) Market Analysis and Forecast 2026-2032

21 December 2025198 pages

Choose your research edition.

Industry ResearchCarbetocin (Duratocin) Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Carbetocin (Duratocin) Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Carbetocin (Duratocin) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Carbetocin (Duratocin) Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Carbetocin (Duratocin) Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Carbetocin (Duratocin) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Carbetocin (Duratocin) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Carbetocin (Duratocin) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Carbetocin (Duratocin) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Carbetocin (Duratocin) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Carbetocin (Duratocin) include Ferring Inc., Hangzhou Dayangchem Co. Ltd., Acinopeptide Co., Ltd., Polypeptide Laboraries France, Leap Labchem Co., Ltd, Clearsynth Canada INC., Chemos GmbH & Co. KG, Chemieliva Pharmaceutical Co., Ltd. and BOC Sciences, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Carbetocin (Duratocin), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Carbetocin (Duratocin), also provides the sales of main regions and countries. Of the upcoming market potential for Carbetocin (Duratocin), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Carbetocin (Duratocin) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Carbetocin (Duratocin) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Carbetocin (Duratocin) sales, projected growth trends, production technology, application and end-user industry.

Carbetocin (Duratocin) Segment by Company

Ferring Inc.

Hangzhou Dayangchem Co. Ltd.

Acinopeptide Co., Ltd.

Polypeptide Laboraries France

Leap Labchem Co., Ltd

Clearsynth Canada INC.

Chemos GmbH & Co. KG

Chemieliva Pharmaceutical Co., Ltd.

BOC Sciences

Beacon Pharmaceuticals Limited

Bachem AG

Acinopeptide Co., Ltd.

Carbetocin (Duratocin) Segment by Type

Carbetocin Tablets

Carbetocin Injection

Carbetocin (Duratocin) Segment by Application

Oxytocic

Antihemorrhagic

Uterotonic

Carbetocin (Duratocin) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Carbetocin (Duratocin) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Carbetocin (Duratocin) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Carbetocin (Duratocin).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Carbetocin (Duratocin) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Carbetocin (Duratocin) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Carbetocin (Duratocin) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Carbetocin (Duratocin) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Carbetocin Tablets Major Manufacturers Table 3. Carbetocin Injection Major Manufacturers Table 4. Global Carbetocin (Duratocin) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Oxytocic Major Manufacturers Table 6. Antihemorrhagic Major Manufacturers Table 7. Uterotonic Major Manufacturers Table 8. Carbetocin (Duratocin) Industry Trends Table 9. Carbetocin (Duratocin) Industry Drivers Table 10. Carbetocin (Duratocin) Industry Opportunities and Challenges Table 11. Carbetocin (Duratocin) Industry Restraints Table 12. Global Carbetocin (Duratocin) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Carbetocin (Duratocin) Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Carbetocin (Duratocin) Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Carbetocin (Duratocin) Revenue Market Share by Region (2021-2026) Table 16. Global Carbetocin (Duratocin) Revenue Market Share by Region (2027-2032) Table 17. Global Carbetocin (Duratocin) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Carbetocin (Duratocin) Sales by Region (2021-2026) & (k units) Table 19. Global Carbetocin (Duratocin) Sales by Region (2027-2032) & (k units) Table 20. Global Carbetocin (Duratocin) Sales Market Share by Region (2021-2026) Table 21. Global Carbetocin (Duratocin) Sales Market Share by Region (2027-2032) Table 22. Global Carbetocin (Duratocin) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Carbetocin (Duratocin) Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Carbetocin (Duratocin) Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Carbetocin (Duratocin) Sales Market Share by Manufacturers (2021-2026) Table 26. Global Carbetocin (Duratocin) Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Carbetocin (Duratocin) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Carbetocin (Duratocin) Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Carbetocin (Duratocin) Manufacturers, Product Type & Application Table 30. Global Carbetocin (Duratocin) Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Carbetocin (Duratocin) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Carbetocin (Duratocin) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Carbetocin (Duratocin) Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Carbetocin (Duratocin) Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Carbetocin (Duratocin) Revenue Market Share by Type (2021-2026) Table 37. Global Carbetocin (Duratocin) Revenue Market Share by Type (2027-2032) Table 38. Global Carbetocin (Duratocin) Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Carbetocin (Duratocin) Sales by Type (2021-2026) & (k units) Table 40. Global Carbetocin (Duratocin) Sales by Type (2027-2032) & (k units) Table 41. Global Carbetocin (Duratocin) Sales Market Share by Type (2021-2026) Table 42. Global Carbetocin (Duratocin) Sales Market Share by Type (2027-2032) Table 43. Global Carbetocin (Duratocin) Price by Type (2021-2026) & (US$/unit) Table 44. Global Carbetocin (Duratocin) Price by Type (2027-2032) & (US$/unit) Table 45. Global Carbetocin (Duratocin) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Carbetocin (Duratocin) Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Carbetocin (Duratocin) Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Carbetocin (Duratocin) Revenue Market Share by Application (2021-2026) Table 49. Global Carbetocin (Duratocin) Revenue Market Share by Application (2027-2032) Table 50. Global Carbetocin (Duratocin) Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Carbetocin (Duratocin) Sales by Application (2021-2026) & (k units) Table 52. Global Carbetocin (Duratocin) Sales by Application (2027-2032) & (k units) Table 53. Global Carbetocin (Duratocin) Sales Market Share by Application (2021-2026) Table 54. Global Carbetocin (Duratocin) Sales Market Share by Application (2027-2032) Table 55. Global Carbetocin (Duratocin) Price by Application (2021-2026) & (US$/unit) Table 56. Global Carbetocin (Duratocin) Price by Application (2027-2032) & (US$/unit) Table 57. Ferring Inc. Company Information Table 58. Ferring Inc. Business Overview Table 59. Ferring Inc. Carbetocin (Duratocin) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Ferring Inc. Carbetocin (Duratocin) Product Portfolio Table 61. Ferring Inc. Recent Development Table 62. Hangzhou Dayangchem Co. Ltd. Company Information Table 63. Hangzhou Dayangchem Co. Ltd. Business Overview Table 64. Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Product Portfolio Table 66. Hangzhou Dayangchem Co. Ltd. Recent Development Table 67. Acinopeptide Co., Ltd. Company Information Table 68. Acinopeptide Co., Ltd. Business Overview Table 69. Acinopeptide Co., Ltd. Carbetocin (Duratocin) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Acinopeptide Co., Ltd. Carbetocin (Duratocin) Product Portfolio Table 71. Acinopeptide Co., Ltd. Recent Development Table 72. Polypeptide Laboraries France Company Information Table 73. Polypeptide Laboraries France Business Overview Table 74. Polypeptide Laboraries France Carbetocin (Duratocin) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Polypeptide Laboraries France Carbetocin (Duratocin) Product Portfolio Table 76. Polypeptide Laboraries France Recent Development Table 77. Leap Labchem Co., Ltd Company Information Table 78. Leap Labchem Co., Ltd Business Overview Table 79. Leap Labchem Co., Ltd Carbetocin (Duratocin) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Leap Labchem Co., Ltd Carbetocin (Duratocin) Product Portfolio Table 81. Leap Labchem Co., Ltd Recent Development Table 82. Clearsynth Canada INC. Company Information Table 83. Clearsynth Canada INC. Business Overview Table 84. Clearsynth Canada INC. Carbetocin (Duratocin) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Clearsynth Canada INC. Carbetocin (Duratocin) Product Portfolio Table 86. Clearsynth Canada INC. Recent Development Table 87. Chemos GmbH & Co. KG Company Information Table 88. Chemos GmbH & Co. KG Business Overview Table 89. Chemos GmbH & Co. KG Carbetocin (Duratocin) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Chemos GmbH & Co. KG Carbetocin (Duratocin) Product Portfolio Table 91. Chemos GmbH & Co. KG Recent Development Table 92. Chemieliva Pharmaceutical Co., Ltd. Company Information Table 93. Chemieliva Pharmaceutical Co., Ltd. Business Overview Table 94. Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Product Portfolio Table 96. Chemieliva Pharmaceutical Co., Ltd. Recent Development Table 97. BOC Sciences Company Information Table 98. BOC Sciences Business Overview Table 99. BOC Sciences Carbetocin (Duratocin) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. BOC Sciences Carbetocin (Duratocin) Product Portfolio Table 101. BOC Sciences Recent Development Table 102. Beacon Pharmaceuticals Limited Company Information Table 103. Beacon Pharmaceuticals Limited Business Overview Table 104. Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Product Portfolio Table 106. Beacon Pharmaceuticals Limited Recent Development Table 107. Bachem AG Company Information Table 108. Bachem AG Business Overview Table 109. Bachem AG Carbetocin (Duratocin) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Bachem AG Carbetocin (Duratocin) Product Portfolio Table 111. Bachem AG Recent Development Table 112. Acinopeptide Co., Ltd. Company Information Table 113. Acinopeptide Co., Ltd. Business Overview Table 114. Acinopeptide Co., Ltd. Carbetocin (Duratocin) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Acinopeptide Co., Ltd. Carbetocin (Duratocin) Product Portfolio Table 116. Acinopeptide Co., Ltd. Recent Development Table 117. North America Carbetocin (Duratocin) Revenue by Type (2021-2026) & (US$ Million) Table 118. North America Carbetocin (Duratocin) Revenue by Type (2027-2032) & (US$ Million) Table 119. North America Carbetocin (Duratocin) Sales by Type (2021-2026) & (k units) Table 120. North America Carbetocin (Duratocin) Sales by Type (2027-2032) & (k units) Table 121. North America Carbetocin (Duratocin) Sales Price by Type (2021-2026) & (US$/unit) Table 122. North America Carbetocin (Duratocin) Sales Price by Type (2027-2032) & (US$/unit) Table 123. North America Carbetocin (Duratocin) Revenue by Application (2021-2026) & (US$ Million) Table 124. North America Carbetocin (Duratocin) Revenue by Application (2027-2032) & (US$ Million) Table 125. North America Carbetocin (Duratocin) Sales by Application (2021-2026) & (k units) Table 126. North America Carbetocin (Duratocin) Sales by Application (2027-2032) & (k units) Table 127. North America Carbetocin (Duratocin) Sales Price by Application (2021-2026) & (US$/unit) Table 128. North America Carbetocin (Duratocin) Sales Price by Application (2027-2032) & (US$/unit) Table 129. North America Carbetocin (Duratocin) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. North America Carbetocin (Duratocin) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 131. North America Carbetocin (Duratocin) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 132. North America Carbetocin (Duratocin) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 133. North America Carbetocin (Duratocin) Sales by Country (2021-2026) & (k units) Table 134. North America Carbetocin (Duratocin) Sales by Country (2027-2032) & (k units) Table 135. North America Carbetocin (Duratocin) Sales Price by Country (2021-2026) & (US$/unit) Table 136. North America Carbetocin (Duratocin) Sales Price by Country (2027-2032) & (US$/unit) Table 137. United States Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Table 138. Canada Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Table 139. Mexico Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Table 140. Europe Carbetocin (Duratocin) Revenue by Type (2021-2026) & (US$ Million) Table 141. Europe Carbetocin (Duratocin) Revenue by Type (2027-2032) & (US$ Million) Table 142. Europe Carbetocin (Duratocin) Sales by Type (2021-2026) & (k units) Table 143. Europe Carbetocin (Duratocin) Sales by Type (2027-2032) & (k units) Table 144. Europe Carbetocin (Duratocin) Sales Price by Type (2021-2026) & (US$/unit) Table 145. Europe Carbetocin (Duratocin) Sales Price by Type (2027-2032) & (US$/unit) Table 146. Europe Carbetocin (Duratocin) Revenue by Application (2021-2026) & (US$ Million) Table 147. Europe Carbetocin (Duratocin) Revenue by Application (2027-2032) & (US$ Million) Table 148. Europe Carbetocin (Duratocin) Sales by Application (2021-2026) & (k units) Table 149. Europe Carbetocin (Duratocin) Sales by Application (2027-2032) & (k units) Table 150. Europe Carbetocin (Duratocin) Sales Price by Application (2021-2026) & (US$/unit) Table 151. Europe Carbetocin (Duratocin) Sales Price by Application (2027-2032) & (US$/unit) Table 152. Europe Carbetocin (Duratocin) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. Europe Carbetocin (Duratocin) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 154. Europe Carbetocin (Duratocin) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 155. Europe Carbetocin (Duratocin) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 156. Europe Carbetocin (Duratocin) Sales by Country (2021-2026) & (k units) Table 157. Europe Carbetocin (Duratocin) Sales by Country (2027-2032) & (k units) Table 158. Europe Carbetocin (Duratocin) Sales Price by Country (2021-2026) & (US$/unit) Table 159. Europe Carbetocin (Duratocin) Sales Price by Country (2027-2032) & (US$/unit) Table 160. Germany Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Table 161. France Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Table 162. U.K. Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Table 163. Italy Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Table 164. Russia Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Table 165. Spain Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Table 166. Netherlands Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Table 167. Switzerland Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Table 168. Sweden Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Table 169. Poland Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Table 170. China Carbetocin (Duratocin) Revenue by Type (2021-2026) & (US$ Million) Table 171. China Carbetocin (Duratocin) Revenue by Type (2027-2032) & (US$ Million) Table 172. China Carbetocin (Duratocin) Sales by Type (2021-2026) & (k units) Table 173. China Carbetocin (Duratocin) Sales by Type (2027-2032) & (k units) Table 174. China Carbetocin (Duratocin) Sales Price by Type (2021-2026) & (US$/unit) Table 175. China Carbetocin (Duratocin) Sales Price by Type (2027-2032) & (US$/unit) Table 176. China Carbetocin (Duratocin) Revenue by Application (2021-2026) & (US$ Million) Table 177. China Carbetocin (Duratocin) Revenue by Application (2027-2032) & (US$ Million) Table 178. China Carbetocin (Duratocin) Sales by Application (2021-2026) & (k units) Table 179. China Carbetocin (Duratocin) Sales by Application (2027-2032) & (k units) Table 180. China Carbetocin (Duratocin) Sales Price by Application (2021-2026) & (US$/unit) Table 181. China Carbetocin (Duratocin) Sales Price by Application (2027-2032) & (US$/unit) Table 182. Asia Carbetocin (Duratocin) Revenue by Type (2021-2026) & (US$ Million) Table 183. Asia Carbetocin (Duratocin) Revenue by Type (2027-2032) & (US$ Million) Table 184. Asia Carbetocin (Duratocin) Sales by Type (2021-2026) & (k units) Table 185. Asia Carbetocin (Duratocin) Sales by Type (2027-2032) & (k units) Table 186. Asia Carbetocin (Duratocin) Sales Price by Type (2021-2026) & (US$/unit) Table 187. Asia Carbetocin (Duratocin) Sales Price by Type (2027-2032) & (US$/unit) Table 188. Asia Carbetocin (Duratocin) Revenue by Application (2021-2026) & (US$ Million) Table 189. Asia Carbetocin (Duratocin) Revenue by Application (2027-2032) & (US$ Million) Table 190. Asia Carbetocin (Duratocin) Sales by Application (2021-2026) & (k units) Table 191. Asia Carbetocin (Duratocin) Sales by Application (2027-2032) & (k units) Table 192. Asia Carbetocin (Duratocin) Sales Price by Application (2021-2026) & (US$/unit) Table 193. Asia Carbetocin (Duratocin) Sales Price by Application (2027-2032) & (US$/unit) Table 194. Asia Carbetocin (Duratocin) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. Asia Carbetocin (Duratocin) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 196. Asia Carbetocin (Duratocin) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 197. Asia Carbetocin (Duratocin) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 198. Asia Carbetocin (Duratocin) Sales by Country (2021-2026) & (k units) Table 199. Asia Carbetocin (Duratocin) Sales by Country (2027-2032) & (k units) Table 200. Asia Carbetocin (Duratocin) Sales Price by Country (2021-2026) & (US$/unit) Table 201. Asia Carbetocin (Duratocin) Sales Price by Country (2027-2032) & (US$/unit) Table 202. Japan Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Table 203. South Korea Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Table 204. India Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Table 205. Australia Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Table 206. Taiwan Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Table 207. Southeast Asia Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Table 208. SAMEA Carbetocin (Duratocin) Revenue by Type (2021-2026) & (US$ Million) Table 209. SAMEA Carbetocin (Duratocin) Revenue by Type (2027-2032) & (US$ Million) Table 210. SAMEA Carbetocin (Duratocin) Sales by Type (2021-2026) & (k units) Table 211. SAMEA Carbetocin (Duratocin) Sales by Type (2027-2032) & (k units) Table 212. SAMEA Carbetocin (Duratocin) Sales Price by Type (2021-2026) & (US$/unit) Table 213. SAMEA Carbetocin (Duratocin) Sales Price by Type (2027-2032) & (US$/unit) Table 214. SAMEA Carbetocin (Duratocin) Revenue by Application (2021-2026) & (US$ Million) Table 215. SAMEA Carbetocin (Duratocin) Revenue by Application (2027-2032) & (US$ Million) Table 216. SAMEA Carbetocin (Duratocin) Sales by Application (2021-2026) & (k units) Table 217. SAMEA Carbetocin (Duratocin) Sales by Application (2027-2032) & (k units) Table 218. SAMEA Carbetocin (Duratocin) Sales Price by Application (2021-2026) & (US$/unit) Table 219. SAMEA Carbetocin (Duratocin) Sales Price by Application (2027-2032) & (US$/unit) Table 220. SAMEA Carbetocin (Duratocin) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 221. SAMEA Carbetocin (Duratocin) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 222. SAMEA Carbetocin (Duratocin) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 223. SAMEA Carbetocin (Duratocin) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 224. SAMEA Carbetocin (Duratocin) Sales by Country (2021-2026) & (k units) Table 225. SAMEA Carbetocin (Duratocin) Sales by Country (2027-2032) & (k units) Table 226. SAMEA Carbetocin (Duratocin) Sales Price by Country (2021-2026) & (US$/unit) Table 227. SAMEA Carbetocin (Duratocin) Sales Price by Country (2027-2032) & (US$/unit) Table 228. Brazil Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Table 229. Argentina Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Table 230. Chile Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Table 231. Colombia Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Table 232. Peru Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Table 233. Saudi Arabia Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Table 234. Israel Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Table 235. UAE Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Table 236. Turkey Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Table 237. Iran Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Table 238. Egypt Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Table 239. Key Raw Materials Table 240. Raw Materials Key Suppliers Table 241. Carbetocin (Duratocin) Distributors List Table 242. Carbetocin (Duratocin) Customers List Table 243. Research Programs/Design for This Report Table 244. Authors List of This Report Table 245. Secondary Sources Table 246. Primary Sources List of Figures Figure 1. Carbetocin (Duratocin) Image Figure 2. Global Carbetocin (Duratocin) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Carbetocin (Duratocin) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Carbetocin Tablets Image Figure 5. Carbetocin Injection Image Figure 6. Global Carbetocin (Duratocin) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Carbetocin (Duratocin) Market Size Share 2021 VS 2025 VS 2032 Figure 8. Oxytocic Image Figure 9. Antihemorrhagic Image Figure 10. Uterotonic Image Figure 11. Global Carbetocin (Duratocin) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Figure 13. Global Carbetocin (Duratocin) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Carbetocin (Duratocin) Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Carbetocin (Duratocin) Revenue Market Share by Region (2021-2032) Figure 16. Global Carbetocin (Duratocin) Sales (2021-2032) & (k units) Figure 17. Global Carbetocin (Duratocin) Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Carbetocin (Duratocin) Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Carbetocin (Duratocin) Sales YoY (2021-2032) & (k units) Figure 20. Europe Carbetocin (Duratocin) Sales YoY (2021-2032) & (k units) Figure 21. China Carbetocin (Duratocin) Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Carbetocin (Duratocin) Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Carbetocin (Duratocin) Sales YoY (2021-2032) & (k units) Figure 24. Global Carbetocin (Duratocin) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Carbetocin (Duratocin) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Carbetocin (Duratocin) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Carbetocin (Duratocin) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Carbetocin (Duratocin) Revenue Market Share by Type (2021-2032) Figure 30. Global Carbetocin (Duratocin) Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Carbetocin (Duratocin) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Carbetocin (Duratocin) Sales Market Share by Type (2021-2032) Figure 33. Global Carbetocin (Duratocin) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Carbetocin (Duratocin) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Carbetocin (Duratocin) Revenue Market Share by Application (2021-2032) Figure 36. Global Carbetocin (Duratocin) Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Carbetocin (Duratocin) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Carbetocin (Duratocin) Sales Market Share by Application (2021-2032) Figure 39. North America Carbetocin (Duratocin) Revenue Share by Type (2021-2032) Figure 40. North America Carbetocin (Duratocin) Sales Share by Type (2021-2032) Figure 41. North America Carbetocin (Duratocin) Revenue Share by Application (2021-2032) Figure 42. North America Carbetocin (Duratocin) Sales Share by Application (2021-2032) Figure 43. North America Carbetocin (Duratocin) Revenue Share by Country (2021-2032) Figure 44. North America Carbetocin (Duratocin) Sales Share by Country (2021-2032) Figure 45. Europe Carbetocin (Duratocin) Revenue Share by Type (2021-2032) Figure 46. Europe Carbetocin (Duratocin) Sales Share by Type (2021-2032) Figure 47. Europe Carbetocin (Duratocin) Revenue Share by Application (2021-2032) Figure 48. Europe Carbetocin (Duratocin) Sales Share by Application (2021-2032) Figure 49. Europe Carbetocin (Duratocin) Revenue Share by Country (2021-2032) Figure 50. Europe Carbetocin (Duratocin) Sales Share by Country (2021-2032) Figure 51. China Carbetocin (Duratocin) Revenue Share by Type (2021-2032) Figure 52. China Carbetocin (Duratocin) Sales Share by Type (2021-2032) Figure 53. China Carbetocin (Duratocin) Revenue Share by Application (2021-2032) Figure 54. China Carbetocin (Duratocin) Sales Share by Application (2021-2032) Figure 55. Asia Carbetocin (Duratocin) Revenue Share by Type (2021-2032) Figure 56. Asia Carbetocin (Duratocin) Sales Share by Type (2021-2032) Figure 57. Asia Carbetocin (Duratocin) Revenue Share by Application (2021-2032) Figure 58. Asia Carbetocin (Duratocin) Sales Share by Application (2021-2032) Figure 59. Asia Carbetocin (Duratocin) Revenue Share by Country (2021-2032) Figure 60. Asia Carbetocin (Duratocin) Sales Share by Country (2021-2032) Figure 61. SAMEA Carbetocin (Duratocin) Revenue Share by Type (2021-2032) Figure 62. SAMEA Carbetocin (Duratocin) Sales Share by Type (2021-2032) Figure 63. SAMEA Carbetocin (Duratocin) Revenue Share by Application (2021-2032) Figure 64. SAMEA Carbetocin (Duratocin) Sales Share by Application (2021-2032) Figure 65. SAMEA Carbetocin (Duratocin) Revenue Share by Country (2021-2032) Figure 66. SAMEA Carbetocin (Duratocin) Sales Share by Country (2021-2032) Figure 67. Carbetocin (Duratocin) Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Carbetocin (Duratocin) Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Carbetocin Tablets
  • Carbetocin Injection
Applications
  • Oxytocic
  • Antihemorrhagic
  • Uterotonic
Companies covered
  • Ferring Inc.
  • Hangzhou Dayangchem Co. Ltd.
  • Acinopeptide Co., Ltd.
  • Polypeptide Laboraries France
  • Leap Labchem Co., Ltd
  • Clearsynth Canada INC.
  • Chemos GmbH & Co. KG
  • Chemieliva Pharmaceutical Co., Ltd.
  • BOC Sciences
  • Beacon Pharmaceuticals Limited
  • Bachem AG
  • Acinopeptide Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Carbetocin (Duratocin) Market by Type
  3. 1.2.1 Global Carbetocin (Duratocin) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Carbetocin Tablets
  5. 1.2.3 Carbetocin Injection
  6. 1.3 Carbetocin (Duratocin) Market by Application
  7. 1.3.1 Global Carbetocin (Duratocin) Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Oxytocic
  9. 1.3.3 Antihemorrhagic
  10. 1.3.4 Uterotonic
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Carbetocin (Duratocin) Market Dynamics
  1. 2.1 Carbetocin (Duratocin) Industry Trends
  2. 2.2 Carbetocin (Duratocin) Industry Drivers
  3. 2.3 Carbetocin (Duratocin) Industry Opportunities and Challenges
  4. 2.4 Carbetocin (Duratocin) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Carbetocin (Duratocin) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Carbetocin (Duratocin) Revenue by Region
  3. 3.2.1 Global Carbetocin (Duratocin) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Carbetocin (Duratocin) Revenue by Region (2021-2026)
  5. 3.2.3 Global Carbetocin (Duratocin) Revenue by Region (2027-2032)
  6. 3.2.4 Global Carbetocin (Duratocin) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Carbetocin (Duratocin) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Carbetocin (Duratocin) Sales by Region
  9. 3.4.1 Global Carbetocin (Duratocin) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Carbetocin (Duratocin) Sales by Region (2021-2026)
  11. 3.4.3 Global Carbetocin (Duratocin) Sales by Region (2027-2032)
  12. 3.4.4 Global Carbetocin (Duratocin) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Carbetocin (Duratocin) Revenue by Manufacturers
  2. 4.1.1 Global Carbetocin (Duratocin) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Carbetocin (Duratocin) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Carbetocin (Duratocin) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Carbetocin (Duratocin) Sales by Manufacturers
  6. 4.2.1 Global Carbetocin (Duratocin) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Carbetocin (Duratocin) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Carbetocin (Duratocin) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Carbetocin (Duratocin) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Carbetocin (Duratocin) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Carbetocin (Duratocin) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Carbetocin (Duratocin) Manufacturers, Product Type & Application
  13. 4.7 Global Carbetocin (Duratocin) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Carbetocin (Duratocin) Market CR5 and HHI
  16. 4.8.2 2025 Carbetocin (Duratocin) Tier 1, Tier 2, and Tier 3
5 Carbetocin (Duratocin) Market by Type
  1. 5.1 Global Carbetocin (Duratocin) Revenue by Type
  2. 5.1.1 Global Carbetocin (Duratocin) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Carbetocin (Duratocin) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Carbetocin (Duratocin) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Carbetocin (Duratocin) Sales by Type
  6. 5.2.1 Global Carbetocin (Duratocin) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Carbetocin (Duratocin) Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Carbetocin (Duratocin) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Carbetocin (Duratocin) Price by Type
6 Carbetocin (Duratocin) Market by Application
  1. 6.1 Global Carbetocin (Duratocin) Revenue by Application
  2. 6.1.1 Global Carbetocin (Duratocin) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Carbetocin (Duratocin) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Carbetocin (Duratocin) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Carbetocin (Duratocin) Sales by Application
  6. 6.2.1 Global Carbetocin (Duratocin) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Carbetocin (Duratocin) Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Carbetocin (Duratocin) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Carbetocin (Duratocin) Price by Application
7 Company Profiles
  1. 7.1 Ferring Inc.
  2. 7.1.1 Ferring Inc. Company Information
  3. 7.1.2 Ferring Inc. Business Overview
  4. 7.1.3 Ferring Inc. Carbetocin (Duratocin) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Ferring Inc. Carbetocin (Duratocin) Product Portfolio
  6. 7.1.5 Ferring Inc. Recent Developments
  7. 7.2 Hangzhou Dayangchem Co. Ltd.
  8. 7.2.1 Hangzhou Dayangchem Co. Ltd. Company Information
  9. 7.2.2 Hangzhou Dayangchem Co. Ltd. Business Overview
  10. 7.2.3 Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Product Portfolio
  12. 7.2.5 Hangzhou Dayangchem Co. Ltd. Recent Developments
  13. 7.3 Acinopeptide Co., Ltd.
  14. 7.3.1 Acinopeptide Co., Ltd. Company Information
  15. 7.3.2 Acinopeptide Co., Ltd. Business Overview
  16. 7.3.3 Acinopeptide Co., Ltd. Carbetocin (Duratocin) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Acinopeptide Co., Ltd. Carbetocin (Duratocin) Product Portfolio
  18. 7.3.5 Acinopeptide Co., Ltd. Recent Developments
  19. 7.4 Polypeptide Laboraries France
  20. 7.4.1 Polypeptide Laboraries France Company Information
  21. 7.4.2 Polypeptide Laboraries France Business Overview
  22. 7.4.3 Polypeptide Laboraries France Carbetocin (Duratocin) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Polypeptide Laboraries France Carbetocin (Duratocin) Product Portfolio
  24. 7.4.5 Polypeptide Laboraries France Recent Developments
  25. 7.5 Leap Labchem Co., Ltd
  26. 7.5.1 Leap Labchem Co., Ltd Company Information
  27. 7.5.2 Leap Labchem Co., Ltd Business Overview
  28. 7.5.3 Leap Labchem Co., Ltd Carbetocin (Duratocin) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Leap Labchem Co., Ltd Carbetocin (Duratocin) Product Portfolio
  30. 7.5.5 Leap Labchem Co., Ltd Recent Developments
  31. 7.6 Clearsynth Canada INC.
  32. 7.6.1 Clearsynth Canada INC. Company Information
  33. 7.6.2 Clearsynth Canada INC. Business Overview
  34. 7.6.3 Clearsynth Canada INC. Carbetocin (Duratocin) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Clearsynth Canada INC. Carbetocin (Duratocin) Product Portfolio
  36. 7.6.5 Clearsynth Canada INC. Recent Developments
  37. 7.7 Chemos GmbH & Co. KG
  38. 7.7.1 Chemos GmbH & Co. KG Company Information
  39. 7.7.2 Chemos GmbH & Co. KG Business Overview
  40. 7.7.3 Chemos GmbH & Co. KG Carbetocin (Duratocin) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Chemos GmbH & Co. KG Carbetocin (Duratocin) Product Portfolio
  42. 7.7.5 Chemos GmbH & Co. KG Recent Developments
  43. 7.8 Chemieliva Pharmaceutical Co., Ltd.
  44. 7.8.1 Chemieliva Pharmaceutical Co., Ltd. Company Information
  45. 7.8.2 Chemieliva Pharmaceutical Co., Ltd. Business Overview
  46. 7.8.3 Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Product Portfolio
  48. 7.8.5 Chemieliva Pharmaceutical Co., Ltd. Recent Developments
  49. 7.9 BOC Sciences
  50. 7.9.1 BOC Sciences Company Information
  51. 7.9.2 BOC Sciences Business Overview
  52. 7.9.3 BOC Sciences Carbetocin (Duratocin) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 BOC Sciences Carbetocin (Duratocin) Product Portfolio
  54. 7.9.5 BOC Sciences Recent Developments
  55. 7.10 Beacon Pharmaceuticals Limited
  56. 7.10.1 Beacon Pharmaceuticals Limited Company Information
  57. 7.10.2 Beacon Pharmaceuticals Limited Business Overview
  58. 7.10.3 Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Product Portfolio
  60. 7.10.5 Beacon Pharmaceuticals Limited Recent Developments
  61. 7.11 Bachem AG
  62. 7.11.1 Bachem AG Company Information
  63. 7.11.2 Bachem AG Business Overview
  64. 7.11.3 Bachem AG Carbetocin (Duratocin) Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Bachem AG Carbetocin (Duratocin) Product Portfolio
  66. 7.11.5 Bachem AG Recent Developments
  67. 7.12 Acinopeptide Co., Ltd.
  68. 7.12.1 Acinopeptide Co., Ltd. Company Information
  69. 7.12.2 Acinopeptide Co., Ltd. Business Overview
  70. 7.12.3 Acinopeptide Co., Ltd. Carbetocin (Duratocin) Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Acinopeptide Co., Ltd. Carbetocin (Duratocin) Product Portfolio
  72. 7.12.5 Acinopeptide Co., Ltd. Recent Developments
8 North America
  1. 8.1 North America Carbetocin (Duratocin) Market Size by Type
  2. 8.1.1 North America Carbetocin (Duratocin) Revenue by Type (2021-2032)
  3. 8.1.2 North America Carbetocin (Duratocin) Sales by Type (2021-2032)
  4. 8.1.3 North America Carbetocin (Duratocin) Price by Type (2021-2032)
  5. 8.2 North America Carbetocin (Duratocin) Market Size by Application
  6. 8.2.1 North America Carbetocin (Duratocin) Revenue by Application (2021-2032)
  7. 8.2.2 North America Carbetocin (Duratocin) Sales by Application (2021-2032)
  8. 8.2.3 North America Carbetocin (Duratocin) Price by Application (2021-2032)
  9. 8.3 North America Carbetocin (Duratocin) Market Size by Country
  10. 8.3.1 North America Carbetocin (Duratocin) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Carbetocin (Duratocin) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Carbetocin (Duratocin) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Carbetocin (Duratocin) Market Size by Type
  2. 9.1.1 Europe Carbetocin (Duratocin) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Carbetocin (Duratocin) Sales by Type (2021-2032)
  4. 9.1.3 Europe Carbetocin (Duratocin) Price by Type (2021-2032)
  5. 9.2 Europe Carbetocin (Duratocin) Market Size by Application
  6. 9.2.1 Europe Carbetocin (Duratocin) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Carbetocin (Duratocin) Sales by Application (2021-2032)
  8. 9.2.3 Europe Carbetocin (Duratocin) Price by Application (2021-2032)
  9. 9.3 Europe Carbetocin (Duratocin) Market Size by Country
  10. 9.3.1 Europe Carbetocin (Duratocin) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Carbetocin (Duratocin) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Carbetocin (Duratocin) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Carbetocin (Duratocin) Market Size by Type
  2. 10.1.1 China Carbetocin (Duratocin) Revenue by Type (2021-2032)
  3. 10.1.2 China Carbetocin (Duratocin) Sales by Type (2021-2032)
  4. 10.1.3 China Carbetocin (Duratocin) Price by Type (2021-2032)
  5. 10.2 China Carbetocin (Duratocin) Market Size by Application
  6. 10.2.1 China Carbetocin (Duratocin) Revenue by Application (2021-2032)
  7. 10.2.2 China Carbetocin (Duratocin) Sales by Application (2021-2032)
  8. 10.2.3 China Carbetocin (Duratocin) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Carbetocin (Duratocin) Market Size by Type
  2. 11.1.1 Asia Carbetocin (Duratocin) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Carbetocin (Duratocin) Sales by Type (2021-2032)
  4. 11.1.3 Asia Carbetocin (Duratocin) Price by Type (2021-2032)
  5. 11.2 Asia Carbetocin (Duratocin) Market Size by Application
  6. 11.2.1 Asia Carbetocin (Duratocin) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Carbetocin (Duratocin) Sales by Application (2021-2032)
  8. 11.2.3 Asia Carbetocin (Duratocin) Price by Application (2021-2032)
  9. 11.3 Asia Carbetocin (Duratocin) Market Size by Country
  10. 11.3.1 Asia Carbetocin (Duratocin) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Carbetocin (Duratocin) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Carbetocin (Duratocin) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Carbetocin (Duratocin) Market Size by Type
  2. 12.1.1 SAMEA Carbetocin (Duratocin) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Carbetocin (Duratocin) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Carbetocin (Duratocin) Price by Type (2021-2032)
  5. 12.2 SAMEA Carbetocin (Duratocin) Market Size by Application
  6. 12.2.1 SAMEA Carbetocin (Duratocin) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Carbetocin (Duratocin) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Carbetocin (Duratocin) Price by Application (2021-2032)
  9. 12.3 SAMEA Carbetocin (Duratocin) Market Size by Country
  10. 12.3.1 SAMEA Carbetocin (Duratocin) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Carbetocin (Duratocin) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Carbetocin (Duratocin) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Carbetocin (Duratocin) Value Chain Analysis
  2. 13.1.1 Carbetocin (Duratocin) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Carbetocin (Duratocin) Production Mode & Process
  6. 13.2 Carbetocin (Duratocin) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Carbetocin (Duratocin) Distributors
  9. 13.2.3 Carbetocin (Duratocin) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst